Mediphage Bioceuticals is a spin-off from the University of Waterloo. Mediphage is a non-viral gene therapy company located at JLabs in Toronto, Canada. Our proprietary core technology, ministring DNA (msDNA), is a novel non-viral vector that is designed to overcome critical challenges facing viral gene therapies and leverage advancements of non-viral gene therapy technologies.

Leveraging the versatility of our msDNA non-viral technology, we are developing innovative solutions to the challenges faced with genetic and infectious diseases that have limited, or no, treatment options available at present.